期刊文献+

EGCG对舌鳞癌细胞CAL-27的EGFR、67LR及VEGF表达的影响 被引量:3

Effect of Epigallocatechin-3-Gallate on the Expression of EGFR,67LR and VEGF in Human Tongue Squamous Cell Carcinoma Cell Line CAL-27
下载PDF
导出
摘要 目的:研究表没食子儿茶素没食子酸酯(epigallocatechin-3-gallate,EGCG)对舌鳞癌细胞CAL-27的表皮生长因子受体(epidermal growth factor receptor,EGFR)、相对分子质量为67 000的层粘连蛋白受体(67 000 dalton lamininreceptor,67LR)及血管内皮生长因子(vascular endothelial growth factor receptor,VEGF)表达的影响,从而揭示EGCG抑致舌鳞癌细胞增殖的可能机制。方法:不同浓度EGCG处理CAL-27细胞24h后,MTT法检测细胞增殖活性;RealTime PCR法和Western Blot法分别检测CAL-27细胞EGFR、67LR、VEGF的mRNA及蛋白表达情况;Western Blot法检测磷酸化EGFR(p-EGFR)的蛋白表达水平。结果:EGCG浓度依赖性抑制CAL-27细胞的增殖,且抑制其EGFR、67LR、VEGF的mRNA和蛋白、p-EGFR的蛋白表达。结论:EGCG能影响EGFR、67LR及VEGF的转录和翻译水平以及p-EGFR蛋白表达,这可能是EGCG抑制舌鳞癌细胞CAL-27增殖的重要机制。 Objective: This study was designed to detect the effect of epigallocatechin-3-gallate (EGCG) on the expression of EGFR, 67LR and VEGF in human tongue squamous cell carcinoma cell line CAL-27, and the role of proliferation inhibition to cancer cells. Methods: Human tongue squamous eell carcinoma cell line CAL-27 were treated with EGCG for 24h. Cell viability was assessed by MTY assay. The mRNA levels of EGFR, 67LR and VEGF were measured by real- time PCR and their protein levels were determined by Western Blot. The protein expression of p-EGFR were evaluated by Western Blot. Results: EGCG showed inhibition effect on CAL-27 ceils proliferation. Suppression effect of the mRNA levels and protein levels of EGFR, 67LR and VEGF, protein levels of p-EGFR were manifested in a close-dependent manner. Conclusion: EGCG inhibited the mRNA and protein expression of EGFR, 67LR and VEGF, as well as protein levels of p-EGFR, which may be associated with its suppression effect of proliferation of CAL-27 cells.
出处 《口腔颌面外科杂志》 CAS 2012年第4期238-241,共4页 Journal of Oral and Maxillofacial Surgery
基金 国家自然科学基金(30840031 30970726) 上海市科委课题(074119615)
关键词 表没食子儿茶素没食子酸酯 舌鳞癌细胞 表皮生长因子受体 层粘连蛋白受体 血管内皮生长因子 epigallocatechin-3-gallate tongue squamous cell carcinoma cell EGFR 67 000 dahon laminin receptor(67LR) VEGF
  • 相关文献

参考文献8

  • 1Yang CS, Wang X, Lu G, et al. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance[J]. Nat Rev Cancer,2009,9(6):429-439.
  • 2陈丽莉,苏俭生.EGCG抗癌靶点中酪氨酸激酶受体RTKs的研究进展[J].同济大学学报(医学版),2011,32(3):116-119. 被引量:2
  • 3Tachibana H, Koga K, Fujimura Y, et al. A receptor for green tea polyphenol EGCG [J]. Nat Struct Mol Biol, 2004,11(4):380-381.
  • 4Margaritescu C, Pirici D, Simionescu C, et al. VEGF and VEGFRs expression in oral squamous cell carcinoma[J]. Rom J Morphol Embryol, 2009, 50(4):527-548.
  • 5Narotzki B, Reznick AZ, Aizenbud D, et al. Green tea: a promising natural product in oral health [J]. Arch Oral Biol, 2012, 57(5):429-435.
  • 6Singh BN, Shankar S, Srivastava RK. Green tea eatechin, epigallocatechin-3-gallate(EGCG): mechanisms, perspec- tives and clinical applications [J]. Bioehem Pharmaeol, 2011, 82(12):1807-1821.
  • 7Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors [J]. Nat Rev Cancer, 2005,5(5):341-354.
  • 8Uehara M, Sano K, Ikeda H, et al. Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma[J]. Oral 0ncol,2004,40(3):321-325.

二级参考文献20

  • 1Hubbard SR,Mohammadi M,Schlessinger J.Auto regulatory mechanisms in protein-tyrosine kinases[J].J Biol Chem,1998,273:11987-11990.
  • 2Mark AL,Joseph S.Cell signaling by receptor tyrosineinases[J].Cell,2010,147 (7):1117-1134.
  • 3Ezwick JB,Ullrich A.Receptor tyrosine kinase signalling as a target for cancer intervention strate-gies[J].Endocrine-Related Cancer,2001,8:161-173.
  • 4Kolibaba KS,Druker BJ.Protein tyrosine kinases and cancer[J].Biochim Biophys Acta,1997,13339 (3):F217 -248.
  • 5Hiromasa Y,Shinichi T,Tetsuya M.Impact of EGFR mutation analysis in non-small cell lung cancer[J].Lung Cancer,2009,63:315-321.
  • 6Nicholson RI,Gee JM,Harper ME.EGFR and cancer prognosis[J].Eur J Cancer,2001,37(Suppl):S9.
  • 7Mikkel WP,Vadim T,Nina P,et al.Expression of a naturally occurring constitu-tively active variant of the epidermal growth factor receptor in mouse fibroblasts increases motility[J].Int J Cancer,2004,108:643 -653.
  • 8Michael VG,Roza Z,Mikkel WP,et al.EGFR escapes down-regulation due to impaired interna-lization and sorting to lysosomes[J].Carcinogenesis,2007,28(7):1408-1417.
  • 9Yoshihisa U,Yasuyo O,Yoshiatsu S,et al.Coexpression of epidermal growth factor receptor and transforming growth factor-a predicts worse prognosis in breast-cancer patients[J].Int J Cancer,2000,89:484-487.
  • 10Garrett TP,McKem NM,Lou M,et al.The crystal structure of a truncated ErbB2 ectodomain reveals an active conformation,poised to interact with other ErbB receptors[J].Mol Cell,2003,11 (2):495 -505.

共引文献1

同被引文献28

  • 1李士坤,陈克河,任庆梅.槲皮素对人食管癌Eca-109细胞的分化诱导作用[J].中国实用医药,2007,2(36):14-15. 被引量:2
  • 2向廷秀,陶小红,姜政,王丕龙,谯敏.槲皮素对SGC-7901胃癌细胞生长及HSP70和EGFR表达的影响[J].西安交通大学学报(医学版),2007,28(4):411-414. 被引量:12
  • 3Ahmad N, Feyes DK, Nieminen AL, et al. Green tea constituent epigallo-catechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells [J]. JNatl Cancer Inst, 1997, 89(24):1881-1886.
  • 4Aldini G, Yeum K J, Carini M, et al. (-)-Epigallocatechin- 3-gallate prevents oxidative damage in both the aqueous and lipid compartments of human plasma [J]. Biochem Biophys Res Commun, 2003, 302(2):409-414.
  • 5Fujimura Y, Umeda D, yano S, et al. The 67 kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCG [J]. Biochem Biophys Res Commun, 2007,364 (1): 79-85.
  • 6Fujimura Y, Umeda D, Yamada K, et al. The impact of the 67 kDa laminin receptor on both cell-surface binding and anti-allergic action of tea catechins [J]. Arch Biochem Biophys, 2008, 476(2): 133-138.
  • 7Navarro RE, Santacmz H, Inoue M. Complexation of epigallocatechin gallate (a green tea extract, egcg) with Mn2+: nuclear spin relaxation by the paramagnetic ion[J]. JInorg Biochem, 2005, 99(2):584-588.
  • 8JBabich H, Krupka ME, Nissim HA, et al. Differential in vitro cytotoxicity of (-)-epicatechin gallate (ECG) to cancer and normal cells from the human oral cavity[J]. Toxicol In Vitro, 2005 (19), 19 (2) :231-242.
  • 9Lira YC, Cha YY. Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anap|astic thyroid carcinoma cells through suppression of EGFR/ ERK pathway and cyclin B1/CDK1 complex [J]. J Surg Oncol, 2011, 104(7):776-780.
  • 10Farooqi AA, Bhatti S, Rana A, et al. Shattering the underpinnings of neoplastic architecture in LNCap: synergistic potential of nutraceuticals in dampening PDGFR/EGFR signaling and cellular proliferation [J]. J Exp Ther Oncol, 2011, 9(3):201-206.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部